Ionis Pharmaceuticals Inc’s recently made public that its Director Hayden Michael R acquired Company’s shares for reported $0.48 million on May 01 ’25. In the deal valued at $31.86 per share,15,000 shares were bought. As a result of this transaction, Hayden Michael R now holds 50,219 shares worth roughly $1.69 million.
Then, Birchler Brian sold 680 shares, generating $19,292 in total proceeds. Upon selling the shares at $28.37, the EVP, Corp and Development Ops now owns 56,660 shares.
Before that, Jenne Kyle sold 3,016 shares. Ionis Pharmaceuticals Inc shares valued at $85,534 were divested by the EVP, Chf GL Pdt Str Ofcr at a price of $28.36 per share. As a result of the transaction, Jenne Kyle now holds 11,199 shares, worth roughly $0.38 million.
H.C. Wainwright initiated its Ionis Pharmaceuticals Inc [IONS] rating to a Buy in a research note published on April 07, 2025; the price target was $45. A number of analysts have revised their coverage, including Redburn Atlantic’s analysts, who began to cover the stock in late March with a ‘”a Neutral”‘ rating. BMO Capital Markets also remained covering IONS and has decreased its forecast on August 02, 2024 with a “Market perform” recommendation from previously “an Outperform” rating. Leerink Partners revised its rating on July 24, 2024. It rated IONS as “an Outperform” which previously was an “a Market perform”.
Price Performance Review of IONS
On Friday, Ionis Pharmaceuticals Inc [NASDAQ:IONS] saw its stock jump 1.73% to $33.56. Over the last five days, the stock has gained 4.03%. Ionis Pharmaceuticals Inc shares have fallen nearly -4.00% since the year began. Nevertheless, the stocks have fallen -12.31% over the past one year. While a 52-week high of $52.34 was reached on 01/02/25, a 52-week low of $23.95 was recorded on 04/09/25. SMA at 50 days reached $30.90, while 200 days put it at $36.54.
Levels Of Support And Resistance For IONS Stock
The 24-hour chart illustrates a support level at 32.96, which if violated will result in even more drops to 32.36. On the upside, there is a resistance level at 33.91. A further resistance level may holdings at 34.26. The Relative Strength Index (RSI) on the 14-day chart is 61.23, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.64, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 9.21%. Stochastics %K at 80.69% indicates the stock is a selling.
